Arrowhead Research Corporation
Records under this name other than the patents Arrowhead Research Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Arrowhead Research Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,981,870 | Rnai-Mediated Inhibition of H1F1A for Treatment of Ocular Angiogenesis Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,940,887 | RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,453,220 | RNAi-MEDIATED INHIBITION OF PHOSPHODIESTERASE TYPE 4 FOR TREATMENT OF cAMP-RELATED OCULAR DISORDERS Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,947,660 | Rnai-Mediated Inhibition of Frizzled Related PROTEIN-1 for Treatment of Glaucoma Formerly held In force · High confidence | In force | High confidence | |
| US 8,222,227 | Rnai-Mediated Inhibition of Histamine Receptor H1-RELATED Conditions Formerly held In force · High confidence | In force | High confidence | |
| US 9,206,428 | RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions Formerly held In force · High confidence | In force | High confidence | |
| US 9,371,529 | RNAi-MEDIATED INHIBITION OF SPLEEN TYROSINE KINASE-RELATED INFLAMMATORY CONDITIONS Formerly held In force · High confidence | In force | High confidence | |
| US 9,447,419 | RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,198,259 | Treatment of Neurological Disorders by Dsrna Administration Formerly held In force · High confidence | In force | High confidence | |
| US 8,017,592 | Rnai-Mediated Inhibition of Histamine Receptor H1-RELATED Conditions Formerly held In force · High confidence | In force | High confidence |